| lncRNA-FTX与脑胶质瘤病人预后的相关性分析 |
| |
| 引用本文： | 胡,荣,赵,武,张亚森,李苑奇.lncRNA-FTX与脑胶质瘤病人预后的相关性分析[J].中国临床神经外科杂志,2021,26(9):679-681. |
| |
| 作者姓名： | 胡 荣 赵 武 张亚森 李苑奇 |
| |
| 作者单位： | 453000 河南，新乡市第一人民医院神经外科（胡 荣、赵 武、张亚森、李苑奇） |
| |
| 摘 要： | 目的 探讨长链非编码RNA（lncRNA）FTX表达水平与脑胶质瘤病人预后的相关性。方法 前瞻性收集2016年1月~2018年1月手术切除的脑胶质瘤88例（46例获得瘤旁组织），采用实时逆转录PCR检测lncRNA FTX表达水平，以脑胶质瘤组织lncRNA FTX表达水平均值为界分为高表达组（n=57）和低表达组（n=31）。术后随访3年，主要观察指标为无进展生存期、总生存期。结果 脑胶质瘤组织lncRNA FTX表达水平（7.54±2.15）]明显高于瘤旁组织（2.65±0.69）；P<0.001]。多因素Cox比例回归风险模型分析显示，lncRNA FTX高表达是脑胶质瘤生存预后不良的独立危险因素（RR=1.589；95% CI 1.004~2.515；P=0.048）。生存曲线分析显示，高表达组无进展生存期（15.10个月）和总生存期（20.24个月）较低表达组（分别为18.96和25.53个月）明显缩短（P<0.05）。结论 脑胶质瘤lncRNA FTX呈高表达，与病人不良生存预后有关。
|
| 关 键 词： | 脑胶质瘤 长链非编码RNA FTX 预后 危险因素 |
Correlation between lncRNA FTX level in glioma tissues and survival prognosis of patients with glioma |
| |
| HU Rong,ZHAO Wu,ZHANG Ya-sen,LI Yuan-qi..Correlation between lncRNA FTX level in glioma tissues and survival prognosis of patients with glioma[J].Chinese Journal of Clinical Neurosurgery,2021,26(9):679-681. |
| |
| Authors: | HU Rong ZHAO Wu ZHANG Ya-sen LI Yuan-qi |
| |
| Affiliation: | Department of Neurosurgery, Xinxiang No.1 People’s Hospital, Xinxiang 453000, China |
| |
| Abstract: | Objective To explore the correlation between the expression level of long non-coding RNA (lncRNA) FTX in glioma tissues and the survival prognosis of patients with glioma. Methods The expression level of lncRNA FTX in glioma tissues obtained from 88 glioma patients who underwent microsurgery from January 2016 to January 2018 and in the tissues adjacent to glioma obtained from 46 glioma patients were detected using PCR, the glioma patients were divided into high expression group (n=57) and low expression group (n=31) based on the mean level of lncRNA FTX in glioma tissues. The patients were followed up for 3 years and the main endpoints were progression free survival and overall survival. Results The expression level of lncRNA FTX in glioma tissues was significantly higher than that in the tissues adjacent to glioma (P<0.05). Multivariate Cox proportional regression risk model analysis showed that high expression of lncRNA FTX was an independent risk factor for poor survival prognosis of glioma patients (RR=1.589; 95% CI 1.004~2.515; P=0.048). Survival curve analysis showed that progression free survival (15.10 months) and overall survival (20.24 months) in the high expression group were significantly shorter than those (18.96 and 25.53 months, respectively) in the lower expression group (P<0.05). Conclusions Human gliomas express high level of lncRNA FTX, which is related to poor survival prognosis. |
| |
| Keywords: | Glioma Long non-coding RNA FTX Prognosis Risk factors |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国临床神经外科杂志》浏览原始摘要信息 |
|
点击此处可从《中国临床神经外科杂志》下载全文 |
